![Marieke Vermeersch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marieke Vermeersch
Public Communications Contact chez
LAKEFRONT BIOTHERAPEUTICS NV
Profil
Marieke Vermeersch is currently the Chief Communication Officer at Galapagos NV.
Previously, she worked as the Director-Investor Relations at Ablynx NV in 2013.
She also served as an Analyst at Banque Degroof Petercam SA (Private Banking) and as an Investor Relations Officer at Omega Pharma NV.
Additionally, she held the position of VP-Investor Relations & Corporate Communications at Hyloris Pharmaceuticals SA. Ms. Vermeersch graduated from Ghent University with a graduate degree and obtained an MBA from Solvay Business School of Economics & Management.
Postes actifs de Marieke Vermeersch
| Sociétés | Poste | Début |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Public Communications Contact | 01/12/2021 |
Anciens postes connus de Marieke Vermeersch
| Sociétés | Poste | Fin |
|---|---|---|
| HYLORIS PHARMACEUTICALS SA | Investor Relations Contact | - |
| OMEGA PHARMA | Public Communications Contact | - |
| ABLYNX | Investor Relations Contact | - |
Banque Degroof Petercam SA (Private Banking)
 Banque Degroof Petercam SA (Private Banking) Investment ManagersFinance Petercam-PB is an active manager with a GARP-oriented investment style. Their investment process relies on in-house fundamental research and combines bottom-up stock selection with top-down macroeconomic considerations. The firm invests a major part of their assets in Eurozone bonds and money-market securities. They also invest significantly in global equity with a strong focus on Europe, and regularly visit the companies in which they invest. They complement their portfolios with global bonds, real estate securities and a limited exposure to alternative investments. | Analyst-Equity | - |
Formation de Marieke Vermeersch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Banque Degroof Petercam SA (Private Banking)
Banque Degroof Petercam SA (Private Banking) Investment ManagersFinance Petercam-PB is an active manager with a GARP-oriented investment style. Their investment process relies on in-house fundamental research and combines bottom-up stock selection with top-down macroeconomic considerations. The firm invests a major part of their assets in Eurozone bonds and money-market securities. They also invest significantly in global equity with a strong focus on Europe, and regularly visit the companies in which they invest. They complement their portfolios with global bonds, real estate securities and a limited exposure to alternative investments. | Finance |
Omega Pharma NV
 Omega Pharma NV Pharmaceuticals: MajorHealth Technology Manufactures and distributes body care pharmaceutical products, vitamins & supplements | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solvay Business School of Economics & Management
 Solvay Business School of Economics & Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hyloris Pharmaceuticals SA
 Hyloris Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products by reformulating well-known drugs | Health Technology |
